HomeCompareAPHMX vs JNJ

APHMX vs JNJ: Dividend Comparison 2026

APHMX yields 16.11% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 APHMX wins by $37.3K in total portfolio value
10 years
APHMX
APHMX
● Live price
16.11%
Share price
$39.27
Annual div
$6.33
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.4K
Annual income
$4,343.69
Full APHMX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — APHMX vs JNJ

📍 APHMX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAPHMXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, APHMX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
APHMX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

APHMX
Annual income on $10K today (after 15% tax)
$1,369.76/yr
After 10yr DRIP, annual income (after tax)
$3,692.14/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, APHMX beats the other by $2,988.52/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of APHMX + JNJ for your $10,000?

APHMX: 50%JNJ: 50%
100% JNJ50/50100% APHMX
Portfolio after 10yr
$38.7K
Annual income
$2,585.74/yr
Blended yield
6.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

APHMX
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

APHMX buys
0
JNJ buys
0
No recent congressional trades found for APHMX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAPHMXJNJ
Forward yield16.11%3.36%
Annual dividend / share$6.33$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$57.4K$20.0K
Annual income after 10y$4,343.69$827.78
Total dividends collected$29.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: APHMX vs JNJ ($10,000, DRIP)

YearAPHMX PortfolioAPHMX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$12,311$1,611.48$10,676$355.77+$1.6KAPHMX
2$15,027$1,854.18$11,407$389.39+$3.6KAPHMX
3$18,195$2,115.16$12,198$426.53+$6.0KAPHMX
4$21,862$2,393.40$13,056$467.62+$8.8KAPHMX
5$26,080$2,687.64$13,987$513.12+$12.1KAPHMX
6$30,902$2,996.44$14,998$563.56+$15.9KAPHMX
7$36,383$3,318.19$16,098$619.52+$20.3KAPHMX
8$42,581$3,651.19$17,295$681.69+$25.3KAPHMX
9$49,555$3,993.63$18,599$750.82+$31.0KAPHMX
10$57,368$4,343.69$20,022$827.78+$37.3KAPHMX

APHMX vs JNJ: Complete Analysis 2026

APHMXStock

The fund normally invests no less than 80% of its net assets plus any borrowings for investment purposes at market value at the time of purchase in the common stocks of medium-sized companies. The advisor defines a medium-sized company as one with a market capitalization greater than the market capitalization of the smallest company in the Russell Midcap® Index and less than three times the weighted average market capitalization of companies in the index.

Full APHMX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this APHMX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

APHMX vs SCHDAPHMX vs JEPIAPHMX vs OAPHMX vs KOAPHMX vs MAINAPHMX vs ABBVAPHMX vs MRKAPHMX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.